NowPatient review
Four manufactured products priced by pack, each with a shipment-and-duties charge that sits in the buy box rather than the headline.
The verdict
NowPatient publishes $215.98 for the smallest Wegovy pen and $251.98 for the Mounjaro KwikPen, read August 2026. A separate $75.00 shipment-and-duties line applies, taking them to $291 and $327.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Liraglutide · Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Injection
- From $291/mo
- Oral
- From $119/mo
- Prescription
- Required
- Compounded
- No
NowPatient sells manufactured GLP-1 products rather than compounded ones: Wegovy, Mounjaro, Saxenda and a Wegovy tablet. Each is priced by pack size and strength.
Who writes the prescription, and what do they see?
A prescription is required before dispensing. The catalog is organized by product and pack rather than by a described course of care.
Naming the actual product, at a stated strength and pack size, is a real advantage over a compounded vial. The duties line is the cost of that advantage and it is disclosed, if not prominently.
What happens when the dose goes up?
Price follows strength and pack size rather than a published ladder. Moving up a strength means a different product listing, not a stated step on a schedule.
What the price includes
The lowest strength and smallest pack of Wegovy is $215.98, which becomes $291 once the $75.00 line is added. Mounjaro is $251.98 and $327. The five-pen Saxenda pack is $440.82 and $516. The thirty-tablet oral Wegovy is $99.00 with a $20.00 line, or $119.
What it claims, and what it cites
These are FDA-approved manufactured medicines, not compounded preparations. That is a meaningful difference: the product in the pen is the product that was tested, at the strength printed on it.
Where it holds up, and where it does not
- Strength: Named manufactured products, not compounds
- Strength: The additional line is shown before checkout
- Strength: Four distinct products carry a figure
- Strength: The oral line carries a lower added charge
- Limitation: No headline figure includes the $75.00
- Limitation: Prices are for the smallest pack and lowest strength
- Limitation: Nothing records which states it serves
- Limitation: Cost rises with strength by product, not by a published schedule
What the evidence says about this kind of treatment
The assessment above is about NowPatient. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who wants a named manufactured product and will read the buy box before deciding.
- Wrong for
- A reader comparing these headlines against a compounded seller's all-in figure.
How NowPatient compares
| Seller | Who it suits | Go |
|---|---|---|
| Navio MD | Readers who want the branded and compounded routes priced side by side | See Navio MD → |
| Midi Health | Readers who want every rung costed, with its milligram, before choosing a first dose | See Midi Health → |
| TrimRx | Readers who already know which molecule they want and will hunt for which tile holds it | See TrimRx → |
More GLP-1 telehealth sellers reviews: NoluNovaNovoCare PharmacyNuBloomNucore HealthNuDay Rx
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- What is the $75.00 line?
- A shipment-and-duties charge shown in the buy box. It applies to the three injection products; the oral carries $20.00 instead.
- Are these compounded?
- No. Wegovy, Mounjaro and Saxenda are manufactured products, so the compounding caveats elsewhere on this site do not apply.
- What does a Wegovy pen actually come to?
- $291 for the lowest strength and smallest pack, once the duties line is included.
- Is NowPatient expensive compared with other GLP-1 telehealth sellers?
- NowPatient publishes a starting figure of $119/mo. Across the 188 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts NowPatient below the median, toward the cheaper end. The other 12 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.